NTRK2 and neoplasm: Studies have shown that inactivation of Trk by tyrosine kinase inhibitors was correlated with more apoptotic [30], or less invasive tumor cells [31], and aiming at interfering TrkB activation might be helpful in the development of effective anticancer therapies.